MedPath

Benefits of lutein in management of eye stress due to long hours of computer usage

Phase 4
Conditions
Health Condition 1: H36- Retinal disorders in diseases classified elsewhere
Registration Number
CTRI/2022/12/048392
Lead Sponsor
Olive life sciences (Pvt) ltd
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Closed to Recruitment of Participants
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Subjects having the MPOD value less than 0.8

2. Subjects who have screen time of 8 hours or more/day (eg., laptop, mobile, etc)

Exclusion Criteria

1. Subjects allergic to lutein

2. Subject with screen time less than that as mentioned in the Inclusion criteria

3. Subjects who refuse to sign Informed Consent Form

4. Pregnant and lactating mothers are excluded from the trial

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. improvement in photoreceptor reflex to blue light <br/ ><br>2. Reduction in disability glare <br/ ><br>3. Improvement in MPOD value <br/ ><br>Timepoint: baseline, 4 and 8 months
Secondary Outcome Measures
NameTimeMethod
1. Improvement in photo stress recoveryTimepoint: baseline, 4 and 8 months
© Copyright 2025. All Rights Reserved by MedPath